Journal
CURRENT OPINION IN PULMONARY MEDICINE
Volume 27, Issue 1, Pages 29-36Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCP.0000000000000738
Keywords
asthma; glucagon-like peptide-1 agonists; metabolic disease; metformin; obesity
Categories
Ask authors/readers for more resources
Disorders of glucose metabolism, including insulin resistance, prediabetes, and diabetes, have been identified as risk factors for worsened asthma. Potential benefits of diabetes medications on asthma outcomes have been investigated. Experimental and epidemiologic studies have shown associations between hyperinsulinemia, glycemic dysfunction, and asthma exacerbations. However, the role of glucose metabolism disorders in asthma remains complex and requires further research to establish their independent impact.
Purpose of review Disorders of glucose metabolism, including insulin resistance, prediabetes, and diabetes, have been identified as risk factors for worsened asthma. This review summarizes emerging evidence for their role as modifiable risk factors in asthma, including the potential benefit of diabetes medications on asthma outcomes. Recent findings Experimental studies show that hyperinsulinemia associated with insulin resistance is associated with airway smooth muscle proliferation and promotes contractility. Epidemiologic studies have identified a higher prevalence of glycemic dysfunction among those with severe and uncontrolled asthma, and longitudinal studies have associated prediabetes and diabetes with higher risk of asthma exacerbations. The potential benefits of thiazolidinediones (TZDs), glucagon-like peptide-1 agonists, and metformin being investigated in asthma, but thus far interventional studies of TZDs have reported null results. On the contrary, observational studies have inconsistently controlled for relevant confounders which leaves conclusions vulnerable to misattribution of relationships due to corelated metabolic disorders, including dyslipidemia. Developing evidence suggests that disorders of glucose metabolism may be associated with worsening asthma. However, these conditions arise within a network of obesity-related metabolic diseases that may themselves worsen asthma. Few interventional trials have not identified a benefit, but data have been limited. Additional research is needed to define the potential independent impact of disorders of glucose metabolism in asthma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available